If you want to search for other Sectors or other Countries, you can check them out here:
Stock investments ranging from Biotech, Pharmaceutical, and Medical Devices in the Healthcare Sector. Covering Clinical Trial recommendations and FDA Approvals.
7/26/13
4 Best Biopharma Stock Trades 2013
Below are some of the best trades in the Biopharma Stock Sector since January 2013. I have gathered my research from a pretty good stock investment forum, 4-Trader. It's all free. I would never ask you to pay for anything on my site. No catches, no gimmicks.
If you want to search for other Sectors or other Countries, you can check them out here:
If you want to search for other Sectors or other Countries, you can check them out here:
6/7/13
Antares Pharma: $ATRS A Risky Buy
Antares Pharmaceuticals is a Hot Biopharma Investment Right Now
So let's start off with Antares Pharma. Most of my previous stocks that I have written about have done very well in the past few years so I'll continue with that trend with this stock: ATRS.
ATRS FDA Approval PDUFA Date is Oct. 14th
Antares PharmaHere's a few web links to help you out on Antares and what they are all about.
- From MarketWatch: ATRS Antares Pharma
- From Yahoo Finance: Big News with Antares Pharma Welcomes Marvin Samson to Board of Directors, from Global Manufacturing Leader, TEVA
- From Morningstar, their analysis of Antares Stock ATRS
- From Seeking Alpha: 4 Top Small Cap Biotech Acquisition Targets: Trius, Antares, Acadia, AcelRx Pharmaceuticals
- From Investor's Hub: ATRS
This is what that blogger from Seeking Alpha, Scott Matusow has to say about Antares. I agree with a commenter that a buyout would be a couple of years down the road.
Antares Pharma (ATRS)
Labels:
$ATRS,
Antares,
antares pharma,
antares pharmaceuticals,
antares stock,
antares stock quote,
atrs,
atrs stock quote,
biopharma,
due diligence,
good buy,
investment,
investor,
Seeking Alpha,
stock buy,
twitter
Subscribe to:
Posts (Atom)